Skip to content

Efficacy of Qi Based Mindfulness Therapy (QMT) on Adult Patients with Psychiatric Illness

Efficacy of Qi Based Mindfulness Therapy (QMT) on Adult Patients with Mild to Moderate Depressive Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106676
Enrollment
Unknown
Registered
2025-07-28
Start date
2023-05-30
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

QMT Exercise group:Qi Based Mindfulness Therapy
Health Education Group:Sleep Hygiene Education

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meets the DSM-5 diagnostic criteria for depressive disorders; 2. Baseline SDS score<72 points, HAMD-17 score<24 points; 3. Age 18-60 years old; 4. Education level of high school or above; 5. Volunteer to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. According to the MINI international neuropsychiatric interview, individuals with other major mental disorders, including schizophrenia spectrum and other psychiatric disorders, bipolar disorder, obsessive-compulsive disorder, dementia, and neurocognitive impairment, are judged to be eligible; 2.Accompanied by a history of drug abuse such as nicotine and drugs; According to MINI, patients who meet the diagnostic criteria for substance related and addictive disorders in DSM-5, as well as individuals with mental disorders caused by substance abuse; 3.Individuals with severe physical diseases, such as diagnosed heart disease, malignant tumors, thyroid diseases, etc; 4. Patients who have previously used psychotropic drugs, such as antidepressants, anti manic drugs, sedatives and hypnotics, or other drugs used to treat mental illness, and have not completed drug elution at the beginning of the trial; 5. Poor compliance and inability to independently cooperate with the experimenter.

Design outcomes

Primary

MeasureTime frame
Polysomnography EEG data;

Secondary

MeasureTime frame
Hamilton Depression Scale score;

Countries

China

Contacts

Public ContactSun Wei

Peking University Sixth Hospital

weisun@bjmu.edu.cn+86 1381003738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026